NEW YORK (Reuters) - Johnson & Johnson will stop selling drug-coated heart stents, a former profit driver for the diversified healthcare company that has stumbled due to safety concerns and fierce competition from rival products.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/lWemFE8pDmc/us-johnsonandjohnson-idUSTRE75E2PK20110615
Alternative Anti Aging Anxiety Aromatherapy Arthritis Asthma
No comments:
Post a Comment